-
Mashup Score: 6
24-week topline data from the phase 2b ASPIRE study in diabetic macular edema (DME) are expected to be released in Q1 of 2025.
Source: www.ophthalmologytimes.comCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 4HanAll Biopharma receives Orphan Drug Designation in Japan for Batoclimab for thyroid eye disease - 13 day(s) ago
Batoclimab is an anti-FcRn treatment being developed for a range of autoimmune diseases and active thyroid eye disease (TED).
Source: www.ophthalmologytimes.comCategories: General Medicine News, OphthalmologyTweet-
HanAll Biopharma received Orphan Drug Designation (ODD) from the Ministry of Health, Labor and Welfare (MHLW) in Japan for Batoclimab, an anti-FcRn treatment being developed for a range of autoimmune diseases and active thyroid eye disease (TED). https://t.co/scmU00mK4w
-
-
Mashup Score: 5Perimeter submits Premarket Approval application with FDA for Perimeter B-Series OCT system - 13 day(s) ago
The Perimeter B-Series OCT system combines proprietary AI technology with optical coherence tomography, for use during breast-conserving surgeries.
Source: www.ophthalmologytimes.comCategories: General Medicine News, OphthalmologyTweet-
Perimeter Medical Imaging AI has submitted a Premarket Approval (PMA) application to the FDA for its Perimeter B-Series OCT system, which combines proprietary AI technology with OCT for use during breast-conserving surgeries https://t.co/hUgAETI1QT
-
-
Mashup Score: 3
The ReNEW study for dry AMD is evaluating the efficacy, safety, and pharmacokinetics of daily subcutaneous injections of elamipretide, a first-in-class mitochondria-targeted investigational therapeutic.
Source: www.ophthalmologytimes.comCategories: General Medicine News, OphthalmologyTweet-
Stealth BioTherapeutics Inc. has reached 50 percent of the enrollment target in the global Phase 3 ReNEW study of elamipretide as a potential treatment in patients with dry AMD. Complete target enrollment is set at 360 trial participants. https://t.co/3tCExMYYs4
-
-
Mashup Score: 4
A survey conducted by the Preservative Freedom Coalition, asked 558 patients with glaucoma or ocular hypertension how they felt about their treatments, the future of their eye health, trust in their doctors and more.
Source: www.ophthalmologytimes.comCategories: General Medicine News, OphthalmologyTweet-
The Preservative Freedom Coalition conducted a nationwide survey with patients with glaucoma and discovered that many patients feel communication with clinicians is lacking. https://t.co/Irx6hjW2d3
-
-
Mashup Score: 3ARVO announces Swathi Kaliki, MD, as recipient of 2025 Ludwig von Sallmann Clinician-Scientist Award - 14 day(s) ago
The award honors Ludwig von Sallmann, MD, a “distinguished international ophthalmologist and ophthalmic investigator whose contributions greatly increased the basic and clinical understanding of vision and ophthalmology.”
Source: www.ophthalmologytimes.comCategories: General Medicine News, OphthalmologyTweet-
The Association for Research in Vision and Ophthalmology (ARVO) Foundation announced the recipient of the Ludwig von Sallmann Clinician-Scientist Award is Swathi Kaliki, MD. Read More: https://t.co/UnApmT4iYn https://t.co/LEjuXngSMh
-
-
Mashup Score: 6
24-week topline data from the phase 2b ASPIRE study in diabetic macular edema (DME) are expected to be released in Q1 of 2025.
Source: www.ophthalmologytimes.comCategories: General Medicine News, OphthalmologyTweet-
Unity Biotechnology announced 24-week topline data from the phase 2b ASPIRE study in diabetic macular edema (DME) are expected to be released in Q1 of 2025, with 36-week data expected in Q2 2025. Read More: https://t.co/eEDSdDwG5e https://t.co/MOx14LjLIx
-
-
Mashup Score: 6Case report: Bilateral retinal detachments in a 19-year-old - 14 day(s) ago
The authors commented that the patient’s “age, relative acute onset, and lack of medical history make this an atypical presentation.”
Source: www.ophthalmologytimes.comCategories: General Medicine News, OphthalmologyTweet-
Investigators published a recent case report describing the development of bilateral retinal detachments in an otherwise healthy 19-year-old man who had been referred to the Cole Eye Institute for evaluation of retinal detachments. https://t.co/YE1IdP2rfa
-
-
Mashup Score: 2
A total of 43 patients who recovered from the SARS-CoV-2 infection with mild pneumonia were included along with 45 healthy individuals.
Source: www.ophthalmologytimes.comCategories: General Medicine News, OphthalmologyTweet-
Researchers from Istanbul, Turkey, conducted a study that found that the choroidal vascularity index (CVI) can shed light on the choroidal vascular physiology in patients who had had mild COVID-19 pneumonia and recovered completely https://t.co/7Cdxp9wY1o
-
-
Mashup Score: 5
Cationic emulsion drops are characterized by their ability to retain cyclosporine A on the ocular surface.
Source: www.ophthalmologytimes.comCategories: General Medicine News, OphthalmologyTweet-
Italian researchers tested the use of cyclosporine A 0.1% cationic emulsion eye drops to prophylactically minimize the discomfort before cataract surgery and found that their use improved ocular surface homeostasis and reduced inflammatory markers. https://t.co/JjDMpXEQpB
-
Unity Biotechnology announced 24-week topline data from the phase 2b ASPIRE study in diabetic macular edema (DME) are expected to be released in Q1 of 2025, with 36-week data expected in Q2 2025. Read More: https://t.co/eEDSdDwG5e https://t.co/MOx14LjLIx